You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2025

Details for Patent: 7,516,741


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,516,741
Title:Aerosolization apparatus with feedback mechanism
Abstract: An aerosolization apparatus comprises a housing defining a chamber having an air inlet and an air outlet, wherein the chamber is sized to receive a capsule containing a pharmaceutical formulation. A puncturing member is moveable within the chamber to contact the capsule and to provide an opening in the capsule, and a feedback mechanism provides an indication, such as a tactile indication, to a user when the puncturing member has been moved to a position where it provides the opening into the capsule. When air flows through the inlet, the pharmaceutical formulation is aerosolized and the aerosolized pharmaceutical formulation is delivered through the outlet.
Inventor(s): Glusker; Mark J. (San Mateo, CA), Wood; Jeff R. (Mountain View, CA), Burr; John D. (Redwood City, CA)
Assignee: Novartis AG (
Application Number:10/704,160
Patent Claim Types:
see list of patent claims
Formulation; Dosage form; Delivery; Device; Use; Process;
Patent landscape, scope, and claims:

United States Patent 7,516,741: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 7,516,741, titled "Aerosolization apparatus with feedback mechanism," is a significant patent in the field of medical devices, particularly those related to aerosolization and respiratory delivery. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Invention Overview

The patent, filed on October 20, 2003, and granted on April 14, 2009, describes an aerosolization apparatus designed to deliver pharmaceutical formulations in an efficient and controlled manner. The apparatus includes a housing with a chamber, an air inlet, and an air outlet, and is equipped with a feedback mechanism to ensure optimal performance[4].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific features and functionalities of the aerosolization apparatus.

Independent Claims

The patent includes several independent claims that define the core aspects of the invention. For example:

  • Claim 1 describes the aerosolization apparatus comprising a housing defining a chamber, an air inlet, and an air outlet, with the chamber sized to receive a capsule containing a pharmaceutical formulation.
  • Claim 10 focuses on the method of aerosolizing a pharmaceutical formulation using the apparatus[4].

Dependent Claims

Dependent claims further specify and narrow down the invention by adding additional features or limitations to the independent claims. These claims help to protect the invention from potential infringements by detailing specific aspects such as the feedback mechanism, user interface, and operational parameters.

Claim Construction and Interpretation

Claim construction is a critical aspect of patent law, as it determines the scope of protection afforded to the patentee. The Federal Circuit has emphasized that claim construction is a question of law, subject to de novo review on appeal[2].

Functional Construction

The claims in this patent may involve functional constructions, where the focus is on what the invention does rather than how it is made. For instance, the feedback mechanism is described in terms of its function—providing feedback to ensure optimal aerosolization—rather than its specific implementation details.

Consistency Across Claims

The Federal Circuit has also clarified that claims must be interpreted consistently across all asserted patents, especially when multiple patents derive from the same parent application. This ensures that the scope of protection is clear and consistent[2].

Patent Landscape and Related Patents

The patent landscape surrounding US 7,516,741 includes other patents related to aerosolization and respiratory delivery devices.

Prior Art and Forward Citations

The patent's prior art includes various references to earlier aerosolization devices and methods. Forward citations, which are patents that cite US 7,516,741, indicate its influence on subsequent innovations in the field. These citations can help in understanding the patent's impact and its position within the broader technological landscape.

Competing Patents

Other patents in the same field, such as those related to automatic dispensers for respiratory delivery devices (e.g., US-11793951-B2), highlight the competitive nature of the patent landscape. These patents often share similar features but may differ in specific details, such as the design of the dispenser or the feedback mechanisms used[5].

Examination Process and Patent Scope

The examination process for US 7,516,741 would have involved a thorough review of the claims to ensure they meet the requirements of novelty, non-obviousness, and enablement. Research has shown that the examination process tends to narrow the scope of patent claims, particularly in terms of claim length and count, to ensure clarity and specificity[3].

Patent Term and Adjustments

The patent term for US 7,516,741 would typically be 20 years from the filing date, subject to any adjustments for delays during the prosecution process. However, the Federal Circuit has clarified that Patent Term Adjustments (PTA) do not extend the term of a patent past the date of a terminal disclaimer, which can be relevant in cases where multiple related patents are involved[1].

Litigation and Enforcement

Patents like US 7,516,741 can be subject to various legal challenges, including inter partes review (IPR) and district court litigation. The validity and scope of the patent claims can be contested, and the court's interpretation of the claims can significantly impact the outcome of such disputes[2].

Industry Impact and Market Domination

The aerosolization apparatus described in US 7,516,741 has the potential to significantly impact the medical device industry, particularly in the treatment of respiratory conditions. By transforming data into actionable insights and optimizing the delivery of pharmaceutical formulations, this invention can help in achieving market domination through improved efficacy and patient compliance.

Key Takeaways

  • Scope and Claims: The patent's scope is defined by its independent and dependent claims, which detail the aerosolization apparatus and its feedback mechanism.
  • Claim Construction: Claims are interpreted functionally and consistently across related patents to ensure clarity and specificity.
  • Patent Landscape: The patent is part of a competitive landscape with other related patents, influencing and being influenced by prior and subsequent innovations.
  • Examination Process: The examination process narrows the scope of claims to ensure novelty, non-obviousness, and enablement.
  • Patent Term: The patent term is subject to adjustments and terminal disclaimers, which can affect the overall duration of protection.
  • Industry Impact: The invention has significant potential to impact the medical device industry, particularly in respiratory treatment.

FAQs

What is the main invention described in US 7,516,741?

The main invention is an aerosolization apparatus with a feedback mechanism designed to deliver pharmaceutical formulations efficiently.

How are the claims in this patent constructed and interpreted?

Claims are constructed functionally and interpreted consistently across related patents to ensure clarity and specificity.

What is the impact of the examination process on patent scope?

The examination process tends to narrow the scope of patent claims to ensure novelty, non-obviousness, and enablement.

How does the patent term adjustment affect the duration of protection for US 7,516,741?

The patent term adjustment does not extend the term past the date of a terminal disclaimer, which can be relevant in cases with multiple related patents.

What is the potential industry impact of this patent?

The invention has the potential to significantly impact the medical device industry, particularly in the treatment of respiratory conditions, by optimizing the delivery of pharmaceutical formulations.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC., United States Court of Appeals for the Federal Circuit, September 16, 2024.
  3. Patent Claims and Patent Scope, Hoover Institution, August 18, 2024.
  4. US7516741B2 - Aerosolization apparatus with feedback mechanism, Google Patents.
  5. US-11793951-B2 - Automatic dispenser for respiratory delivery device and method, PubChem.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 7,516,741

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.